Ozempic, Wegovy users’ grocery bills shrinking along with their waistlines, new study shows
Households that start taking blockbuster GLP-1 appetite suppressants like Ozempic and Wegovy slash food spending within months, according to a study.
Seven Biopharma Trends to Watch in 2026
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last spring. Blair cited the SPDR S&P Biotech exchange-traded fund (NYSE Arca: XBI), which bounced back from $66.66 a share on April […]
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help […]
Oral Wegovy approved. The $100 billion weight loss drug market sees the start of the “pill vs. injection” showdown.
The FDA has just approved the first oral GLP-1 drug for weight management. Clinical data shows it can reduce weight by about 16%, which is essentially comparable to the effects of injections. As someone who has consistently followed the pharmaceutical sector, I believe we underestimate how many people have needle phobia or simply prefer the […]
Novo Nordisk Strikes First With Oral Wegovy — But Can It Outrun Lilly’s Looming Pill?
Quick Read Novo Nordisk (NVO) received FDA approval for the first oral Wegovy pill. The once-daily tablet delivered 16.6% average weight loss over 64 weeks. Novo Nordisk priced the oral Wegovy at $149 per month for the lowest dose. The injectable version costs $349 monthly. Eli Lilly could win approval for its oral GLP-1 drug […]
Novo Nordisk’s Wegovy Pill Becomes First FDA-Approved Oral GLP-1 Drug for Weight Loss
Beyond weight reduction and long-term maintenance of weight loss, the FDA decision for oral Wegovy covers use of the once-daily pill for reducing the risk of major cardiovascular events. Novo Nordisk expects the Wegovy tablet will launch in early January. The post Novo Nordisk’s Wegovy Pill Becomes First FDA-Approved Oral GLP-1 Drug for Weight Loss […]
FDA approves first pill version of GLP-1 drugs
FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind – CBS News
FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind CBS News F.D.A. Approves Wegovy Weight-Loss Pill The New York Times Novo Nordisk stock surges on hopes Wegovy pill approval will deliver some ‘redemption’ for investors CNBC With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN U.S. […]
Novo’s Wegovy pill to test demand from consumers with cash – Reuters
Novo’s Wegovy pill to test demand from consumers with cash Reuters Novo Nordisk stock surges on hopes Wegovy pill approval will deliver some ‘redemption’ for investors CNBC The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know. The Washington Post With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN […]
FDA Approves Wegovy Weight-Loss Pill
(MedPage Today) — The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 mg pill is approved to lower…